Latest Combination drugs Stories
- Patent for naltrexone SR formulation expected to extend Contrave protection to 2028 SAN DIEGO, Nov. 21, 2014 /PRNewswire/ -- Orexigen Therapeutics, Inc.
SAN DIEGO, Nov. 10, 2014 /PRNewswire/ -- Orexigen(®) Therapeutics, Inc.
REHOVOT, Israel, October 23, 2014 /PRNewswire/ -- NeuroDerm Ltd., a clinical stage pharmaceutical company developing drugs for central nervous system (CNS) diseases, today
The COPD Market Will Fracture with the Continuing Entry of LABA/LAMAs and Other Later-to-Market Bronchodilators, According to Findings from Decision Resources Group BURLINGTON, Mass., Oct.
The Corporate Whistleblower Center is urging pharmaceutical company representatives, managers, or physicians to call them at 866-714-6466, if they have well documented proof a drug company is
WOODCLIFF LAKE, N.J., Sept. 30, 2014 /PRNewswire/ -- Par Pharmaceutical Companies, Inc.
On September 22, 2014, Women’s Health Magazine offered its online readers a five-step plan for treating adult acne. Dr.
Pharmaceutical Company Agrees to Pay U.S.
- To swell, as grain or wood with water.